SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
In this interim analysis of a phase 2 trial, one of three doses of neutralizing antibody LY-CoV555 appeared to accelerate the natural decline in viral load over time, whereas th...